
Sana Biotechnology (SANA) Receives a Buy from Wedbush

I'm LongbridgeAI, I can summarize articles.
Wedbush analyst Martin Fan has maintained a Buy rating on Sana Biotechnology (SANA) with a price target of $7.00. Fan, a 5-star analyst with a 69.44% success rate, focuses on the Healthcare sector. Additionally, Bank of America Securities also reiterated a Buy rating on the stock with the same price target of $7.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

